Abstract
To assess the correlation between functional and anatomical evaluations with multifocal electroretinography (mfERG) and spectral-domain optical coherence tomography (SD-OCT) in patients with Parkinson’s disease (PD). This cross-sectional study involved 116 eyes of 58 patients with PD and 30 age- and sex-matched control subjects. All study participants underwent a comprehensive neuro-ophthalmic examination, retinal single-layer thicknesses and volumes, and peripapillary retinal nerve fiber layer (pRNFL) measurements with SD-OCT, and the patients’ mfERG recordings were evaluated. The macular retinal nerve fiber layer (mRNFL), ganglion cell layer (GCL), inner plexiform layer (IPL), outer nuclear layer (ONL), retinal pigment epithelium (RPE), and photoreceptor layer (PR) thicknesses, and mRNFL, RPE, and PR volumes were found lower in PD compared to those of controls, while outer plexiform layer (OPL) volumes were increased (p < 0.05). We found delayed implicit times and decreased amplitudes in the mfERG of PD patients versus those in control subjects (p < 0.05). We found significant correlations between outer macular volumes, PR thicknesses, and N1 amplitudes of rings 2 and 3and P1 amplitudes of rings 3, 4, and 5. Our study revealed thinning of both inner and outer retinal single layers, increased OPL volume, and delayed implicit times and decreased amplitudes in the mfERG of PD patients versus control subjects and correlation between structural and functional parameters. Our findings point out that SD-OCT and mfERG could both serve as non-invasive tools for evaluating ophthalmic manifestations of Parkinson’s disease.
Similar content being viewed by others
References
Park A, Stacy M (2009) Non-motor symptoms in Parkinson’s disease. J Neurol 256(Suppl 3):293–298. https://doi.org/10.1007/s00415-009-5240-1
Bodis-Wollner I (2009) Retinopathy in Parkinson disease. J Neural Transm (Vienna) 116(11):1493–1501. https://doi.org/10.1007/s00702-009-0292-z
Price MJ, Feldman RG, Adelberg D, Kayne H (1992) Abnormalities in color vision and contrast sensitivity in Parkinson’s disease. Neurology 42(4):887–890. https://doi.org/10.1212/WNL.42.4.887
Demirci S, Gunes A, Koyuncuoglu HR, Tok L, Tok O (2016) Evaluation of corneal parameters in patients with Parkinson’s disease. Neurol Sci 37(8):1247–1252. https://doi.org/10.1007/s10072-016-2574-1
Seigo MA, Sotirchos ES, Newsome S, Babiarz A, Eckstein C, Ford ET, Oakley JD, Syc SB, Frohman TC, Ratchford JN, Balcer LJ, Frohman EM, Calabresi PA, Saidha S (2012) In vivo assessment of retinal neuronal layers in multiple sclerosis with manual and automated optical coherence tomography segmentation techniques. J Neurol 259(10):2119–2130. https://doi.org/10.1007/s00415-012-6466-x
Garcia-Martin E, Rodriguez-Mena D, Satue M, Almarcegui C, Dolz I, Alarcia R, Seral M, Polo V, Larrosa JM, Pablo LE (2014) Electrophysiology and optical coherence tomography to evaluate Parkinson disease severity. Invest Ophthalmol Vis Sci 55(2):696–705. https://doi.org/10.1167/iovs.13-13062
Hood DC et al (2012) ISCEV standard for clinical multifocal electroretinography (mfERG) (2011 edition). Doc Ophthalmol 124(1):1–13. https://doi.org/10.1007/s10633-011-9296-8
Miri S, Glazman S, Mylin L, Bodis-Wollner I (2016) A combination of retinal morphology and visual electrophysiology testing increases diagnostic yield in Parkinson’s disease. Parkinsonism Relat Disord 22(Suppl 1):S134–S137. https://doi.org/10.1016/j.parkreldis.2015.09.015
La Morgia C, Barboni P, Rizzo G, Carbonelli M, Savini G, Scaglione C, Capellari S, Bonazza S, Giannoccaro MP, Calandra-Buonaura G, Liguori R, Cortelli P, Martinelli P, Baruzzi A, Carelli V (2013) Loss of temporal retinal nerve fibers in Parkinson disease: a mitochondrial pattern? Eur J Neurol 20(1):198–201. https://doi.org/10.1111/j.1468-1331.2012.03701.x
Reichmann H (2010) Clinical criteria for the diagnosis of Parkinson’s disease. Neurodegener Dis 7(5):284–290. https://doi.org/10.1159/000314478
Ramaker C, Marinus J, Stiggelbout AM, van Hilten BJ (2002) Systematic evaluation of rating scales for impairment and disability in Parkinson’s disease. Mov Disord 17(5):867–876. https://doi.org/10.1002/mds.10248
Gonzalez-Lopez JJ et al (2014) Comparative diagnostic accuracy of ganglion cell-inner plexiform and retinal nerve fiber layer thickness measures by Cirrus and Spectralis optical coherence tomography in relapsing-remitting multiple sclerosis. Biomed Res Int 2014:128517
Garcia-Martin E, Larrosa JM, Polo V, Satue M, Marques ML, Alarcia R, Seral M, Fuertes I, Otin S, Pablo LE (2014) Distribution of retinal layer atrophy in patients with Parkinson disease and association with disease severity and duration. Am J Ophthalmol 157(2):470–478 e2. https://doi.org/10.1016/j.ajo.2013.09.028
Altintas O et al (2008) Correlation between retinal morphological and functional findings and clinical severity in Parkinson’s disease. Doc Ophthalmol 116(2):137–146. https://doi.org/10.1007/s10633-007-9091-8
Hajee ME, March WF, Lazzaro DR, Wolintz AH, Shrier EM, Glazman S, Bodis-Wollner IG (2009) Inner retinal layer thinning in Parkinson disease. Arch Ophthalmol 127(6):737–741. https://doi.org/10.1001/archophthalmol.2009.106
Rohani M, Langroodi AS, Ghourchian S, Falavarjani KG, SoUdi R, Shahidi G (2013) Retinal nerve changes in patients with tremor dominant and akinetic rigid Parkinson’s disease. Neurol Sci 34(5):689–693. https://doi.org/10.1007/s10072-012-1125-7
Albrecht P, Müller AK, Südmeyer M, Ferrea S, Ringelstein M, Cohn E, Aktas O, Dietlein T, Lappas A, Foerster A, Hartung HP, Schnitzler A, Methner A (2012) Optical coherence tomography in parkinsonian syndromes. PLoS One 7(4):e34891. https://doi.org/10.1371/journal.pone.0034891
Archibald NK, Clarke MP, Mosimann UP, Burn DJ (2011) Retinal thickness in Parkinson’s disease. Parkinsonism Relat Disord 17(6):431–436. https://doi.org/10.1016/j.parkreldis.2011.03.004
Tsironi EE, Dastiridou A, Katsanos A, Dardiotis E, Veliki S, Patramani G, Zacharaki F, Ralli S, Hadjigeorgiou GM (2012) Perimetric and retinal nerve fiber layer findings in patients with Parkinson’s disease. BMC Ophthalmol 12(1):54. https://doi.org/10.1186/1471-2415-12-54
Schneider M, Müller HP, Lauda F, Tumani H, Ludolph AC, Kassubek J, Pinkhardt EH (2014) Retinal single-layer analysis in Parkinsonian syndromes: an optical coherence tomography study. J Neural Transm (Vienna) 121(1):41–47. https://doi.org/10.1007/s00702-013-1072-3
Lee JY, Kim JM, Ahn J, Kim HJ, Jeon BS, Kim TW (2014) Retinal nerve fiber layer thickness and visual hallucinations in Parkinson’s disease. Mov Disord 29(1):61–67. https://doi.org/10.1002/mds.25543
Satue M, Seral M, Otin S, Alarcia R, Herrero R, Bambo MP, Fuertes MI, Pablo LE, Garcia-Martin E (2014) Retinal thinning and correlation with functional disability in patients with Parkinson’s disease. Br J Ophthalmol 98(3):350–355. https://doi.org/10.1136/bjophthalmol-2013-304152
Roth NM, Saidha S, Zimmermann H, Brandt AU, Isensee J, Benkhellouf-Rutkowska A, Dornauer M, Kühn AA, Müller T, Calabresi PA, Paul F (2014) Photoreceptor layer thinning in idiopathic Parkinson’s disease. Mov Disord 29(9):1163–1170. https://doi.org/10.1002/mds.25896
Brandt AU, Paul F, Saidha S (2014) Reply to: photoreceptor layer thinning in Parkinsonian syndromes. Mov Disord 29(9):1223–1224. https://doi.org/10.1002/mds.25936
Muller AK et al (2014) Photoreceptor layer thinning in parkinsonian syndromes. Mov Disord 29(9):1222–1223. https://doi.org/10.1002/mds.25939
Chorostecki J, Seraji-Bozorgzad N, Shah A, Bao F, Bao G, George E, Gorden V, Caon C, Frohman E, Tariq Bhatti M, Khan O (2015) Characterization of retinal architecture in Parkinson’s disease. J Neurol Sci 355(1–2):44–48. https://doi.org/10.1016/j.jns.2015.05.007
Spund B, Ding Y, Liu T, Selesnick I, Glazman S, Shrier EM, Bodis-Wollner I (2013) Remodeling of the fovea in Parkinson disease. J Neural Transm (Vienna) 120(5):745–753. https://doi.org/10.1007/s00702-012-0909-5
Bodis-Wollner I (2013) Foveal vision is impaired in Parkinson’s disease. Parkinsonism Relat Disord 19(1):1–14. https://doi.org/10.1016/j.parkreldis.2012.07.012
Moschos MM, Tagaris G, Markopoulos I, Margetis I, Tsapakis S, Kanakis M, Koutsandrea C (2011) Morphologic changes and functional retinal impairment in patients with Parkinson disease without visual loss. Eur J Ophthalmol 21(1):24–29. https://doi.org/10.5301/EJO.2010.1318
Palmowski-Wolfe AM, Perez MT, Behnke S, Fuss G, Martziniak M, Ruprecht KW (2006) Influence of dopamine deficiency in early Parkinson’s disease on the slow stimulation multifocal-ERG. Doc Ophthalmol 112(3):209–215. https://doi.org/10.1007/s10633-006-0008-8
Saidha S, Syc SB, Ibrahim MA, Eckstein C, Warner CV, Farrell SK, Oakley JD, Durbin MK, Meyer SA, Balcer LJ, Frohman EM, Rosenzweig JM, Newsome SD, Ratchford JN, Nguyen QD, Calabresi PA (2011) Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography. Brain 134(Pt 2):518–533. https://doi.org/10.1093/brain/awq346
Papakostopoulos D, Fotiou F, Dean Hart JC, Banerji NK (1989) The electroretinogram in multiple sclerosis and demyelinating optic neuritis. Electroencephalogr Clin Neurophysiol 74(1):1–10. https://doi.org/10.1016/0168-5597(89)90045-2
Zucco G, Zeni MT, Perrone A, Piccolo I (2001) Olfactory sensitivity in early-stage Parkinson patients affected by more marked unilateral disorder. Percept Mot Skills 92(3 Pt 1):894–898. https://doi.org/10.2466/pms.2001.92.3.894
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
All the patients enrolled provided informed written consent, and this study was reviewed and approved by the EU institutional review board.
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Unlu, M., Gulmez Sevim, D., Gultekin, M. et al. Correlations among multifocal electroretinography and optical coherence tomography findings in patients with Parkinson’s disease. Neurol Sci 39, 533–541 (2018). https://doi.org/10.1007/s10072-018-3244-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-018-3244-2